19-17762785-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001161359.2(FCHO1):c.-100G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
FCHO1
NM_001161359.2 5_prime_UTR_premature_start_codon_gain
NM_001161359.2 5_prime_UTR_premature_start_codon_gain
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 0.00100
Genes affected
FCHO1 (HGNC:29002): (FCH and mu domain containing endocytic adaptor 1) Enables AP-2 adaptor complex binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in cytosol; nucleoplasm; and plasma membrane. Is active in clathrin-coated pit. Implicated in primary immunodeficiency disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.041762114).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FCHO1 | NM_015122.3 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENST00000596536.6 | NP_055937.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FCHO1 | ENST00000699203 | c.-100G>T | 5_prime_UTR_premature_start_codon_gain_variant | 3/22 | ENSP00000514201.1 | |||||
FCHO1 | ENST00000596536.6 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | 5 | NM_015122.3 | ENSP00000470731.1 | ||
FCHO1 | ENST00000699212.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/30 | ENSP00000514208.1 | ||||
FCHO1 | ENST00000594202.6 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | 5 | ENSP00000473001.1 | |||
FCHO1 | ENST00000596309.6 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | 4 | ENSP00000470511.2 | |||
FCHO1 | ENST00000596951.6 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | 5 | ENSP00000472417.1 | |||
FCHO1 | ENST00000600209.6 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | 5 | ENSP00000469075.2 | |||
FCHO1 | ENST00000600676.5 | c.51G>T | p.Glu17Asp | missense_variant | 4/28 | 2 | ENSP00000470493.1 | |||
FCHO1 | ENST00000699176.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514179.1 | ||||
FCHO1 | ENST00000699177.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514180.1 | ||||
FCHO1 | ENST00000699207.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514204.1 | ||||
FCHO1 | ENST00000699209.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514206.1 | ||||
FCHO1 | ENST00000699215.1 | c.51G>T | p.Glu17Asp | missense_variant | 4/28 | ENSP00000514211.1 | ||||
FCHO1 | ENST00000699202.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514200.1 | ||||
FCHO1 | ENST00000699214.1 | c.51G>T | p.Glu17Asp | missense_variant | 4/28 | ENSP00000514210.1 | ||||
FCHO1 | ENST00000699208.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/28 | ENSP00000514205.1 | ||||
FCHO1 | ENST00000699198.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/29 | ENSP00000514196.1 | ||||
FCHO1 | ENST00000699199.1 | c.51G>T | p.Glu17Asp | missense_variant | 4/28 | ENSP00000514197.1 | ||||
FCHO1 | ENST00000699213.1 | c.51G>T | p.Glu17Asp | missense_variant | 4/28 | ENSP00000514209.1 | ||||
FCHO1 | ENST00000699197.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/28 | ENSP00000514195.1 | ||||
FCHO1 | ENST00000699200.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/28 | ENSP00000514198.1 | ||||
FCHO1 | ENST00000699196.1 | c.51G>T | p.Glu17Asp | missense_variant | 5/27 | ENSP00000514194.1 | ||||
FCHO1 | ENST00000699203 | c.-100G>T | 5_prime_UTR_variant | 3/22 | ENSP00000514201.1 | |||||
FCHO1 | ENST00000699201.1 | n.51G>T | non_coding_transcript_exon_variant | 5/28 | ENSP00000514199.1 | |||||
FCHO1 | ENST00000699205.1 | n.51G>T | non_coding_transcript_exon_variant | 5/27 | ENSP00000514202.1 | |||||
FCHO1 | ENST00000699206.1 | n.51G>T | non_coding_transcript_exon_variant | 5/29 | ENSP00000514203.1 | |||||
FCHO1 | ENST00000699210.1 | n.51G>T | non_coding_transcript_exon_variant | 5/28 | ENSP00000514207.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251462Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135902
GnomAD3 exomes
AF:
AC:
1
AN:
251462
Hom.:
AF XY:
AC XY:
1
AN XY:
135902
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461718Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727196
GnomAD4 exome
AF:
AC:
2
AN:
1461718
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
727196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 07, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FCHO1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with aspartic acid at codon 17 of the FCHO1 protein (p.Glu17Asp). The glutamic acid residue is moderately conserved and there is a small physicochemical difference between glutamic acid and aspartic acid. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T;T;.;T;T;T;T;T;.;.;.;T;T;.;T;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;.;T;T;T;T;T;.;T;T;T;T;T;T;T;T;T;.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;N;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;N;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Benign
Sift
Benign
.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0020
.;B;B;.;.;.;.;.;B;.;.;.;.;.;.;.;.;.;B;.;.
Vest4
MutPred
Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);Loss of ubiquitination at K12 (P = 0.1343);.;
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at